Showing 241 - 260 results of 392 for search '(( 10 (((per OR peter) decrease) OR (((nn decrease) OR (mean decrease)))) ) OR ( 6 18 decrease ))*', query time: 0.17s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245
  6. 246
  7. 247
  8. 248

    Does pharmacist-supervised intervention through pharmaceutical care program influence direct healthcare cost burden of newly diagnosed diabetics in a tertiary care teaching hospita... by Upadhyay, Dinesh Kumar

    Published 2016
    “…Methods An interventional, pre-post non-clinical randomised controlled study was conducted among randomly distributed 162 [control (n = 54), test 1 (n = 54) and test 2 (n = 54) groups] newly diagnosed diabetics by a consecutive sampling method for 18 months. Direct healthcare costs (direct medical and non-medical costs) from patients perspective was estimated by ‘bottom up’ approach to identify their out-of-pocket expenses (1USD = NPR 73.38) before and after intervention at the baseline, 3, 6, 9 and 12 months follow-ups. …”
    Get full text
    Get full text
  9. 249
  10. 250

    Antiferromagnetism in EuPdGe3 by Albedah, M.A.

    Published 2014
    “…EuPdGe3 crystallizes in the BaNiSn3-type tetragonal structure (space group I4mm) with the lattice constants a=4.4457(1)Å and c=10.1703(2)Å. The results are consistent with EuPdGe3 being an antiferromagnet with the Néel temperature TN=12.16(1)K and with the Eu spins S=7/2 in the ab plane. …”
    Get full text
    Get full text
  11. 251
  12. 252
  13. 253

    Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: A study protocol for a randomised controlled trial by Zidan, Amani

    Published 2016
    “…Patients are eligible for enrolment if they are at least 18 years of age and are discharged from any non-surgical cardiology service with ACS. …”
    Get full text
    Get full text
  14. 254
  15. 255
  16. 256

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…Patient cohorts with excessive polypharmacy (≥9 medications) had the highest probability of survival up to 1.6 years compared to those with lower medication thresholds (≤4); the mortality rate decreased by 18% for patients with excessive polypharmacy [HR=0.82, 95% CI: 0.71 – 0.94]). …”
    Get full text
    Get full text
    Get full text
  17. 257
  18. 258

    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 by Stein Emil, Vollset

    Published 2024
    “…In the assessment of alternative future scenarios, the combined effects of the scenarios (Safer Environment, Improved Childhood Nutrition and Vaccination, and Improved Behavioural and Metabolic Risks scenarios) demonstrated an important decrease in the global burden of DALYs in 2050 of 15·4% (13·5–17·5) compared with the reference scenario, with decreases across super-regions ranging from 10·4% (9·7–11·3) in the high-income super-region to 23·9% (20·7–27·3) in north Africa and the Middle East. …”
    Get full text
    Get full text
    Get full text
  19. 259

    Fish communities and environmental variables during dry season in Pampanga estuary (Philippines) by Abroguena, Jeff Bogart R.

    Published 2020
    “…Number of species generally did not vary between neap (20) and spring tide (18), but showed a decreasing pattern from lower to the upper estuary. …”
    Get full text
    Get full text
    Get full text
  20. 260